Lifeboat Foundation

[3:19] Rajesh Rao and Andrea Stocco test the first human brain-to-brain interface, allowing the brain to be controlled over the internet. When Rajesh plays a video game and thinks about firing at a target, the EEG picks up the signal and sends it across the internet, the Transcranial Magnetic Stimulation or TMS stimulates the region of Andrea’s brain that controls hand movement. This causes Andrea’s index finger to fire the cannon and blow up the target. [Source: World Science Festival YouTube link] Comments.

One of the biggest challenges in treating brain cancer has been getting drugs to cross the blood-brain barrier and attack tumours where they’re needed.

But scientists say they’ve now developed a truly soluble liquid aspirin that can make its way into the brain, and, in the lab at least, kill cancerous glioblastoma cells without harming healthy brain tissue.

The research hasn’t been published in a peer-reviewed journal as yet, so we need to take it with a big pinch of salt for now. But scientists from the Brain Tumour Research Centre at the University of Portsmouth in the UK just presented it at the Brain Tumours 2016 conference in Poland.

Continue reading “Scientists say they’ve developed aspirin that crosses the blood-brain barrier” »

This article is a bit odd to me. Why? Because the way 5D printing is describe is not that much more advance than 3D printing. In fact, 4D printing (as shown by Mitsubishi Lads) prints an object that self evolves/ assembles itself into the object specification submitted to the printer. In another article, it was highlighted that 5D printing would take the 4D printing formation and apply technology that enables the object/s to have intelligence to repair/ evolve over time. So, at this point 5D is still being defined.

3D-printed parts made with five-axis technology are stronger and use less material.

Continue reading “3D Printing + Five Axes = 5D Printing?” »

Researchers have identified nerve cell communication between specific brain regions, providing insight for the development of new therapeutic strategies, and new information on possible motivation for bullying.

Two interconnected brain areas — the hippocampus and the entorhinal cortex — help us to know where we are and to remember it later. By studying these brain areas, researchers at Baylor College of Medicine, Rice University, The University of Texas MD Anderson Cancer Center and the National Cancer Institute have uncovered new information about how dysfunction of this circuit may contribute to memory loss in Alzheimer’s disease. Their results appear in Cell Reports.

“We created a new mouse model in which we showed that spatial memory decays when the entorhinal cortex is not functioning properly,” said co-corresponding author Dr. Joanna Jankowsky, associate professor of neuroscience at Baylor. “I think of the entorhinal area as a funnel. It takes information from other sensory cortices — the parts of the brain responsible for vision, hearing, smell, touch, and taste — and funnels it into the hippocampus. The hippocampus then binds this disparate information into a cohesive memory that can be reactivated in full by recalling only one part. But the hippocampus also plays a role in spatial navigation by telling us where we are in the world. These two functions converge in the same cells, and our study set out to examine this duality.”

The new mouse model was genetically engineered to carry a particular surface receptor on the cells of the entorhinal cortex. When this receptor was activated by administering the drug ivermectin to the mice, the cells of the entorhinal cortex silenced their activity. They stopped funnelling information to the hippocampus. This system allowed the scientists to turn off the entorhinal cortex, and to determine how this affected hippocampal function.

A drink containing liquid aspirin could extend the lives of thousands of brain cancer patients, according to breakthrough research.

British experts have found that the simple drug can cross the ‘blood-brain barrier’ — a hurdle which has so far stopped cancer drugs attacking brain tumours.

Scientists will today announce the results of early tests which show liquid aspirin is ten times more effective than any existing chemotherapy at killing brain cancer cells.

Continue reading “How liquid aspirin could help fight brain cancer: Special version of the drug found to be ten times more effective at killing cancer cells than chemotherapy” »

BMI technology is like anything else; you have an evolution process to finally reach a level of maturity. The good news is that at least at this point of time BMI is at least in that cycle where we are no longer crawling and trying to stand up. We’re in that stage of the cycle where we are standing up and taking a couple of steps at a time. In the next 3 to 5 years, things should be extremely interesting in the BMI space especially as we begin to introduce more sophisticated technology to our connected infrastructure.

Will future soldiers be able to use a direct brain interface to control their hardware?

Imagine if the brain could tell a machine what to do without having to type, speak or use other standard interfaces. That’s the aim of the US Defense Advanced Research Projects Agency (DARPA), which has committed US$60 million to a Neural Engineering System Design (NESD) project to do just that.

Continue reading “Futures: Interfacing with DARPA’s cyborg soldiers” »

Excellent start in using GPU for mapping and predictive analysis on brain functioning and reactions; definitely should prove interesting to medical & tech researchers and engineers across the board should find this interesting.

MIS Asia offers Information Technology strategy insight for senior IT management — resources to understand and leverage information technology from a business leadership perspective.

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer’s disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.

The study, which comes jointly from the Buck Institute for Research on Aging and the UCLA Easton Laboratories for Neurodegenerative Disease Research, is the first to objectively show that memory loss in patients can be reversed, and improvement sustained, using a complex, 36-point therapeutic personalized program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.

“All of these patients had either well-defined mild cognitive impairment (MCI), subjective cognitive impairment (SCI) or had been diagnosed with AD before beginning the program,” said author Dale Bredesen, MD, a professor at the Buck Institute and professor at the Easton Laboratories for Neurodegenerative Disease Research at UCLA, who noted that patients who had had to discontinue work were able to return to work and those struggling at their jobs were able to improve their performance. “Follow up testing showed some of the patients going from abnormal to normal.”

Continue reading “Pre and post testing show reversal of memory loss from Alzheimer’s disease in 10 patients” »